GOVX - GeoVax Labs, Inc. New

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.6 0.0 (0.76%)	---	---	0.0 (-0.02%)	0.0 (0.71%)	0.0 (0.3%)	0.01 (0.94%)	0.01 (0.94%)

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.35
Diluted EPS:
Basic P/E:: -1.714
Diluted P/E:
RSI(14) 1m:: 0.0
VWAP:: 0.6
RVol:

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.57 -0.02 (-3.39%)	Oct 15 17:28
10m	Price decrease 10m	0.57 -0.02 (-3.63%)	Oct 15 17:28
1m	Price increase 1m	0.6 +0.01 (+1.36%)	Oct 15 16:58